LENACAPAVIR
UNII A9A0O6FB4H

Substance Identification & Data

This profile provides standardized clinical and technical data for Lenacapavir, uniquely identified by the FDA Unique Ingredient Identifier (UNII) A9A0O6FB4H.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2189684-44-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

A9A0O6FB4H

CAS Registry Number

2189684-44-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LENACAPAVIR

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

A9A0O6FB4H

The specific atomic composition represented as a molecular structure string.

InChIKey

C39H32ClF10N7O5S2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

BRYXUCLEHAUSDY-WEWMWRJBSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C174616

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

133082658

Unique identification number in the NCBI database of chemical substances.

INN ID

11108

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

JK-52

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(Cn1nc(c2c1C([C@]3([C@@]2(C3)[H])[H])(F)F)C(F)(F)F)(=O)N[C@@H](Cc4cc(cc(c4)F)F)c5c(ccc(n5)C#CC(C)(S(=O)(=O)C)C)-c6ccc(c7c(nn(c67)CC(F)(F)F)NS(=O)(=O)C)Cl

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lenacapavir. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LENACAPAVIR

Common Names & Synonyms

GS-HIV

LENACAPAVIR [INN]

LENACAPAVIR [USAN]

LENACAPAVIR [WHO-DD]

Systematic Nomenclature

1H-CYCLOPROPA(3,4)CYCLOPENTA(1,2-C)PYRAZOLE, N-((1S)-1-(3-(4-CHLORO-3-((METHYLSULFONYL)AMINO)-1-(2,2,2-TRIFLUOROETHYL)-1H-INDAZOL-7-YL)-6-(3-METHYL-3-(METHYLSULFONYL)-1-BUTYN-1-YL)-2-PYRIDINYL)-2-(3,5-DIFLUOROPHENYL)ETHYL)-5,5-DIFLUORO-3B,4,4A,5-TETRAHYDRO-3-(TRIFLUOROMETHYL)-, (3BS,4AR)-

SYS

N-((1S)-1-(3-(4-CHLORO-3-(METHANESULFONAMIDO)-1-(2,2,2-TRIFLUOROETHYL)-1H-INDAZOL-7-YL)-6-(3-(METHANESULFONYL)-3-METHYLBUT-1-YN-1-YL)PYRIDIN-2-YL)-2-(3,5- DIFLUOROPHENYL)ETHYL)-2-((3BS,4AR)-5,5-DIFLUORO-3-(TRIFLUOROMETHYL)-3B,4,4A,5-TETRAHYDRO-1H-CYCLOPROPA(3,4)CYCLOPENTA(1,2-C)PYRAZOL-1-YL)ACETAMIDE

SYS